Delivery Order SPE2DB22D1041-SPE2DB25FUBJ5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,267.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $15,404.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive delivery order utilizes firm fixed pricing and is sourced from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal healthcare operations....
- The Defense Logistics Agency awarded a delivery order valued at $2,961.21 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $20,764.92 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitive, non-set-aside contract employs firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $10,844.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, which is not set-aside, represents a single pharmaceutical procurement under the company's broader contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,578.57 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is sourced from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $6,475.44. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and specifies...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $7,039.81. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by July 30, 2025. The contract fulfillment will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $8,178.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed price contract. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUBJ5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $45,026.91 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical through December 2026, which enables the company to supply a wide range of pharmaceutical products and medical supplies globally to support military healthcare programs. The contract vehicle facilitates deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Jardiance, a diabetes medication, aligns with AmerisourceBergen's established portfolio of specialty pharmaceuticals and represents the company's continued role as a prime pharmaceutical vendor supporting federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.0k | 8/7/25 |